BIM
GILD icon

BlackRock Investment Management’s Gilead Sciences GILD Stock Holding History

BlackRock Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-33,800
Closed -$2.4M – 4057
2014
Q1 		$2.4M Buy
+33,800
New +$2.65M ﹤0.01% 1909

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Investment Management's GILD Position: Q4 2016 in Review

BlackRock Investment Management reduced its Gilead Sciences (GILD) stake by 0.99% in Q4 2016, selling an estimated $4.14M and leaving 5,591,136 shares worth $400M. The position accounts for 0.46% of the portfolio, ranked #37.

BlackRock Investment Management first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $447M in Q3 2016. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • BlackRock Investment Management held 5,591,136 shares of Gilead Sciences worth $400M as of Q4 2016.
  • BlackRock Investment Management sold 55,717 Gilead Sciences shares in Q4 2016, an estimated $4.14M.
  • Gilead Sciences made up 0.46% of BlackRock Investment Management's portfolio in Q4 2016, its #37 holding.
  • BlackRock Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Gilead Sciences position peaked at $447M in Q3 2016.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.